Topics

Articles

Serialization systems are going into operation around the world, but cross-industry collaboration awaits new legislation

2012 Product Security Report

With partial support from manufacturers themselves, home health services are emerging as a critical channel for specialties

Home infusion enhances specialty pharmaceutical distribution

Oncology combines some of the most life-changing therapeutic events with the most complex commercialization pathways. Rising costs of treatments simply add to the tension

Navigating the tense, complex oncology market

As FDA makes progress on an active surveillance system, drug manufacturers and third-party drug safety vendors navigate their own set of challenges

Adding rigor to the adverse event reporting process

But the global picture is sunny as most of the global market growth benefits the generic makers

Generics Manufacturers Grapple With Tight Economics

Even as diagnosed (and “prediabetes”) cases rise worldwide, healthcare providers struggle with patients to control the course of the disease. New therapies—and new health services—are aiding in the battle

THE ONGOING DIABETES BATTLEGROUND

Trends in site selection, regional economic development and business expansion

For a Lucky Few, Biopharma Expansion a Reality Again

A looming crisis in drug-resistant anti-infectives is not being met with a commensurate industry effort. Governments and industry are trying to cope

The Struggle to Get Anti-Infectives on a Faster Track to Commercialization

As hundreds of candidate drugs receive official “orphan” status, the Orphan Drug Act gets re-examined. Meanwhile, these drugs are driving the growth of specialty pharmacy

Rare Diseases and Orphan Drugs Lift Pharma Innovation

The 2010 PDMA Sharing Conference: Expanding Our Focus With More Learning Opportunities